All Updates

All Updates

icon
Filter
Funding
Enifer secures EUR 36 million to begin construction of mycoprotein facility
Next-gen Foods
May 23, 2024
This week:
M&A
Funding
TravelPerk raises USD 135 million in debt funding for expansion; acquires AmTrav
Travel Tech
Yesterday
Product updates
Apple announces Apple Pay Later shutdown
Buy Now, Pay Later
Jun 17, 2024
Management news
Velo3D appoints Brad Kreger as permanent CEO
Additive Manufacturing
Jun 17, 2024
Partnerships
Perplexity partners with SoftBank for AI search engine promotion in Japan
Generative AI Applications
Jun 17, 2024
Product updates
Runway launches Gen-3 Alpha for generating video clips
Generative AI Applications
Jun 17, 2024
Product updates
Adobe integrates Firefly into Acrobat with chat support across multiple documents in Acrobat AI Assistant
Generative AI Applications
Jun 17, 2024
Funding
Amplify Life raises USD 20 million in Series B to expand product suite
InsurTech: Personal Lines
Jun 17, 2024
Funding
Tinybird raises USD 30 million in Series B funding to improve real-time data analytics platform
Data Infrastructure & Analytics
Jun 17, 2024
Partnerships
The EVERY Company collaborates with Grupo Palacios to develop hen-less omelets
Plant-based Dairy & Egg
Jun 17, 2024
Partnerships
Believer Meats partners with AGWA to propel cultivated meat industry in MENA region
Cell-cultured Meat
Jun 17, 2024
Next-gen Foods

Next-gen Foods

May 23, 2024

Enifer secures EUR 36 million to begin construction of mycoprotein facility

Funding

  • Enifer, a Finnish biotech firm, has secured a new funding package of EUR 24 million (~USD 25.9 million), enabling the company to begin construction of its mycoprotein facility. This funding adds to the previously reported EUR 12 million (~USD 13.2 million), bringing the total raised to EUR 36 million (~USD 39.1 million).

  • The new funding package consisted of EUR 15 million (~USD 16.2 million) in Series B funding led by Taaleri Bioindustry Fund I, a EUR 7 million (~USD 7.6 million) junior loan from the Finnish Climate Fund, and a EUR 2 million (~USD 2.1 million) climate and environment loan by Finnerva. Existing investors Nordic Foodtech VC, Voima Ventures, and Valio also participated in this round.

  • The new facility will cost an estimated EUR 33 million (~USD 35.7 million) and have the capacity to produce up to 3,000 tons of PEKILO mycoprotein protein annually, catering to ~40,000 people. It is slated for completion by 2025, with Enifer planning to scale up operations by 2026 to produce 500 kg of mycoprotein per hour.

  • Analyst QuickTake: The company's flagship product, PEKILO, is a single-cell mycoprotein consisting of up to 70% protein, along with beta-glucan, fibers, minerals, and fat. It is color- and taste-neutral and can be used in aquafeed, pet food, and alternative meat applications.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.